About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Other
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Symbol: CPIX
- CUSIP: 23077010
Key Metrics:
- Previous Close: $4.98
- 50 Day Moving Average: $4.70
- 200 Day Moving Average: $4.62
- 52-Week Range: $4.20 - $6.50
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $75.77M
- Outstanding Shares: 16,225,000
- Beta: 1.17
Profitability:- Net Margins: -0.07%
- Return on Equity: 2.40%
- Return on Assets: 2.03%
Debt:- Debt-to-Equity Ratio: 0.05%
- Current Ratio: 7.20%
- Quick Ratio: 6.64%
Additional Links:
Companies Related to Cumberland Pharmaceuticals:
Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/1/2016 | | | | | | | | |
| 8/2/2016 | Q216 | | $0.04 | $8.90 million | $7.40 million | View | N/A |  |
| 5/10/2016 | Q116 | | $0.02 | $8.70 million | $7.70 million | View | Listen | |
| 3/3/2016 | Q415 | | $0.03 | $29.93 million | $8.04 million | View | N/A | |
| 11/3/2015 | Q315 | | $0.04 | $29.93 million | $7.90 million | View | N/A | |
| 8/4/2015 | Q215 | | $0.09 | $29.93 million | $8.90 million | View | N/A | |
| 5/7/2015 | Q115 | | $0.09 | $8.10 million | $8.70 million | View | N/A | |
| 3/3/2015 | Q414 | | $0.10 | $8.05 million | $9.30 million | View | N/A | |
| 5/13/2014 | Q114 | | $0.02 | $10.26 million | $8.09 million | View | N/A | |
| 3/4/2014 | Q4 13 | $0.05 | ($0.08) | | | View | N/A | |
| 11/5/2013 | Q313 | | ($0.04) | $7.60 million | $6.50 million | View | N/A | |
| 8/6/2013 | Q2 2013 | $0.02 | ($0.03) | $9.40 million | $7.10 million | View | N/A | |
| 5/2/2013 | Q113 | $0.05 | $0.05 | $10.00 million | $10.30 million | View | N/A | |
| 2/28/2013 | Q4 2012 | $0.14 | $0.09 | $13.87 million | $13.70 million | View | N/A | |
| 11/1/2012 | Q312 | $0.09 | $0.10 | $13.05 million | $12.50 million | View | N/A | |
| 8/2/2012 | | $0.07 | $0.09 | | | View | N/A | |
| 5/3/2012 | | $0.05 | $0.02 | | | View | N/A | |
| 2/29/2012 | | $0.05 | $0.04 | | | View | N/A | |
| 11/3/2011 | | $0.06 | $0.09 | | | View | N/A | |
| 8/4/2011 | | $0.04 | $0.11 | | | View | N/A | |
| 5/5/2011 | | $0.03 | $0.03 | | | View | N/A | |
| 3/8/2011 | | $0.03 | $0.04 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Cumberland Pharmaceuticals (NASDAQ:CPIX)Insider Ownership Percentage: 37.00%
Institutional Ownership Percentage: 32.31%
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/17/2016 | Thomas R Lawrence | Director | Sell | 3,000 | $4.60 | $13,800.00 | |
| 5/26/2016 | Thomas R Lawrence | Director | Sell | 3,000 | $4.55 | $13,650.00 | |
| 11/19/2015 | Thomas R Lawrence | Director | Sell | 4,000 | $5.61 | $22,440.00 | |
| 3/19/2015 | Thomas R Lawrence | Director | Sell | 6,000 | $6.95 | $41,700.00 | |
| 11/20/2014 | Thomas R Lawrence | Director | Sell | 10,000 | $5.12 | $51,200.00 | |
| 8/21/2014 | Thomas R Lawrence | Director | Sell | 15,000 | $5.08 | $76,200.00 | |
| 3/19/2014 | Thomas Lawrence | Director | Sell | 20,000 | $4.54 | $90,800.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Cumberland Pharmaceuticals (NASDAQ:CPIX)| Date | Headline |
|---|
 | BRIEF-Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S (NASDAQ:CPIX)
feeds.reuters.com - September 26 at 9:07 AM |
 | Cumberland Pharmaceuticals : Announces New Program To Develop Portaban™ For Portal Hypertension (NASDAQ:CPIX)
www.4-traders.com - September 14 at 9:35 PM |
| BRIEF-Cumberland reports new program to develop Portaban for Portal Hypertension (NASDAQ:CPIX)
feeds.reuters.com - September 14 at 4:54 PM |
 | Cumberland Pharmaceuticals Announces New Program To Develop Portaban™ For Portal Hypertension (NASDAQ:CPIX)
www.publicnow.com - September 14 at 4:25 PM |
 | ETF’s with exposure to Cumberland Pharmaceuticals, Inc. : September 8, 2016 (NASDAQ:CPIX)
www.capitalcube.com - September 8 at 4:12 PM |
 | Cumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. Wholesalers (NASDAQ:CPIX)
www.streetinsider.com - August 24 at 9:37 AM |
 | Director of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Lawrence Thomas R, sells 3,000 shares worth $13,800 (NASDAQ:CPIX)
empowerednews.net - August 20 at 4:24 PM |
 | New Study: Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic SWOT Analysis Review (NASDAQ:CPIX)
www.live-pr.com - August 19 at 3:28 PM |
| ETF’s with exposure to Cumberland Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:CPIX)
www.capitalcube.com - August 11 at 4:28 PM |
| Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:CPIX)
www.capitalcube.com - August 9 at 5:23 PM |
 | Cumberland posts 2Q loss (NASDAQ:CPIX)
sg.finance.yahoo.com - August 2 at 9:56 PM |
 | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:CPIX)
www.twst.com - August 2 at 4:29 PM |
| Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - August 2 at 4:29 PM |
| Q2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX)
biz.yahoo.com - August 2 at 9:12 AM |
| Cumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - July 26 at 4:18 PM |
| ETF’s with exposure to Cumberland Pharmaceuticals, Inc. : July 20, 2016 (NASDAQ:CPIX)
www.capitalcube.com - July 20 at 12:17 PM |
 | Shares Trading unchanged at $4.65 Cumberland Pharmaceuticals To… (NASDAQ:CPIX)
www.fidaily.com - July 19 at 10:36 AM |
| Cumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference (NASDAQ:CPIX)
finance.yahoo.com - July 18 at 9:00 AM |
| Cumberland Pharmaceuticals Announces Caroline Young To Join Its Board Of Directors (NASDAQ:CPIX)
www.publicnow.com - June 10 at 8:19 AM |
| Lawrence Thomas R, Director of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) sells 3,000 shares (NASDAQ:CPIX)
empowerednews.net - May 28 at 6:57 AM |
| Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CPIX)
www.capitalcube.com - May 17 at 2:21 PM |
| CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CPIX)
biz.yahoo.com - May 13 at 4:59 PM |
| Edited Transcript of CPIX earnings conference call or presentation 10-May-16 8:30pm GMT (NASDAQ:CPIX)
finance.yahoo.com - May 10 at 6:33 PM |
| Cumberland reports 1Q loss (NASDAQ:CPIX)
sg.finance.yahoo.com - May 10 at 5:36 PM |
| Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - May 10 at 4:18 PM |
| Q1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX)
biz.yahoo.com - May 10 at 7:07 AM |
| Cumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - May 3 at 4:40 PM |
| Cumberland Pharmaceuticals Inc (CPIX): Ariel Investments Snapping Up Shares (NASDAQ:CPIX)
feedproxy.google.com - April 8 at 10:41 AM |
| Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results (NASDAQ:CPIX)
finance.yahoo.com - February 25 at 4:05 PM |
| Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics (NASDAQ:CPIX)
finance.yahoo.com - February 10 at 8:30 AM |
| CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CPIX)
biz.yahoo.com - February 1 at 6:13 AM |
| Piramal Critical Care And Cumberland Pharmaceuticals Announce Launch Of Caldolor And Vaprisol Co-Promotion (NASDAQ:CPIX)
www.publicnow.com - January 25 at 8:27 AM |
| Cumberland Pharmaceuticals, Inc. (CPIX) (NASDAQ:CPIX)
finance.yahoo.com - January 17 at 8:05 PM |
| Cumberland Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:CPIX)
www.capitalcube.com - December 21 at 12:23 PM |
| CUMBERLAND PHARMACEUTICALS INC Financials (NASDAQ:CPIX)
finance.yahoo.com - December 8 at 1:17 PM |
| Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing (NASDAQ:CPIX)
finance.yahoo.com - December 7 at 8:30 AM |
| Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 3 (NASDAQ:CPIX)
finance.yahoo.com - November 30 at 9:05 AM |
| CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events (NASDAQ:CPIX)
biz.yahoo.com - November 24 at 5:23 PM |
 | Caldolor® Launched In Australia For Treatment Of Pain And Fever (NASDAQ:CPIX)
www.noodls.com - November 23 at 4:20 PM |
| Caldolor Approved For Use In Pediatric Patients (NASDAQ:CPIX)
finance.yahoo.com - November 23 at 9:20 AM |
Cumberland Pharmaceuticals (NASDAQ:CPIX) Chart for Tuesday, September, 27, 2016
